Smartleaf Asset Management LLC Novo Cure LTD Transaction History
Smartleaf Asset Management LLC
- $981 Billion
- Q4 2024
A detailed history of Smartleaf Asset Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 184 shares of NVCR stock, worth $3,902. This represents 0.0% of its overall portfolio holdings.
Number of Shares
184
Previous 339
45.72%
Holding current value
$3,902
Previous $5.29 Million
4.59%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
74.3MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$257 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$250 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$168 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$91.4 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$59.5 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.23B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...